Logo image of XSPA

XPRESSPA GROUP INC (XSPA) Stock Fundamental Analysis

NASDAQ:XSPA - Nasdaq - US98420U7037 - Common Stock - Currency: USD

0.655  -0.04 (-5.65%)

After market: 0.6501 0 (-0.75%)

Fundamental Rating

3

Taking everything into account, XSPA scores 3 out of 10 in our fundamental rating. XSPA was compared to 73 industry peers in the Diversified Consumer Services industry. While XSPA seems to be doing ok healthwise, there are quite some concerns on its profitability. XSPA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year XSPA has reported negative net income.
XSPA had a positive operating cash flow in the past year.
XSPA Yearly Net Income VS EBIT VS OCF VS FCFXSPA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 -20M -40M -60M -80M

1.2 Ratios

Industry RankSector Rank
ROA -3.28%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XSPA Yearly ROA, ROE, ROICXSPA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 200 -200 -400

1.3 Margins

Industry RankSector Rank
OM -0.24%
PM (TTM) -3.55%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XSPA Yearly Profit, Operating, Gross MarginsXSPA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 -200 -400 -600 -800 -1K

More info and screens

5

2. Health

2.1 Basic Checks

XSPA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XSPA has been increased compared to 1 year ago.
XSPA has a better debt/assets ratio than last year.
XSPA Yearly Shares OutstandingXSPA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M
XSPA Yearly Total Debt VS Total AssetsXSPA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M

2.2 Solvency

XSPA has an Altman-Z score of -2.74. This is a bad value and indicates that XSPA is not financially healthy and even has some risk of bankruptcy.
XSPA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.74
ROIC/WACCN/A
WACC8.27%
XSPA Yearly LT Debt VS Equity VS FCFXSPA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 5.93 indicates that XSPA has no problem at all paying its short term obligations.
A Quick Ratio of 5.84 indicates that XSPA has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 5.93
Quick Ratio 5.84
XSPA Yearly Current Assets VS Current LiabilitesXSPA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 88.67% over the past year.
XSPA shows a strong growth in Revenue. In the last year, the Revenue has grown by 417.44%.
Measured over the past years, XSPA shows a very strong growth in Revenue. The Revenue has been growing by 43.80% on average per year.
EPS 1Y (TTM)88.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)417.44%
Revenue growth 3Y13.75%
Revenue growth 5Y43.8%
Sales Q2Q%49.55%

3.2 Future

XSPA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.45% yearly.
Based on estimates for the next years, XSPA will show a small growth in Revenue. The Revenue will grow by 0.23% on average per year.
EPS Next Y-814%
EPS Next 2Y-172.76%
EPS Next 3Y-11.28%
EPS Next 5Y10.45%
Revenue Next Year-2.07%
Revenue Next 2Y0.7%
Revenue Next 3Y0.05%
Revenue Next 5Y0.23%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
XSPA Yearly Revenue VS EstimatesXSPA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
XSPA Yearly EPS VS EstimatesXSPA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2017 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200 -250

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XSPA. In the last year negative earnings were reported.
Also next year XSPA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XSPA Price Earnings VS Forward Price EarningsXSPA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -2.35
XSPA Per share dataXSPA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

XSPA's earnings are expected to decrease with -11.28% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-172.76%
EPS Next 3Y-11.28%

More info and screens

0

5. Dividend

5.1 Amount

XSPA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XPRESSPA GROUP INC

NASDAQ:XSPA (10/24/2022, 8:00:02 PM)

After market: 0.6501 0 (-0.75%)

0.655

-0.04 (-5.65%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)08-15 2022-08-15/amc
Earnings (Next)11-14 2022-11-14/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners1.84%
Ins Owner Change0%
Market Cap61.58M
Analysts82.86
Price Target2.04 (211.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.1%
Min EPS beat(2)21.57%
Max EPS beat(2)34.64%
EPS beat(4)3
Avg EPS beat(4)56.94%
Min EPS beat(4)-50.98%
Max EPS beat(4)222.55%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)10.34%
Min Revenue beat(2)-0.7%
Max Revenue beat(2)21.38%
Revenue beat(4)3
Avg Revenue beat(4)47.5%
Min Revenue beat(4)-0.7%
Max Revenue beat(4)163.26%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.66
P/FCF N/A
P/OCF 7.94
P/B 0.86
P/tB 0.99
EV/EBITDA -2.35
EPS(TTM)-0.04
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.08
OCFY12.6%
SpS1
BVpS0.76
TBVpS0.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.28%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -0.24%
PM (TTM) -3.55%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 330.54%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.93
Quick Ratio 5.84
Altman-Z -2.74
F-Score8
WACC8.27%
ROIC/WACCN/A
Cap/Depr(3y)119.29%
Cap/Depr(5y)89.95%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-814%
EPS Next 2Y-172.76%
EPS Next 3Y-11.28%
EPS Next 5Y10.45%
Revenue 1Y (TTM)417.44%
Revenue growth 3Y13.75%
Revenue growth 5Y43.8%
Sales Q2Q%49.55%
Revenue Next Year-2.07%
Revenue Next 2Y0.7%
Revenue Next 3Y0.05%
Revenue Next 5Y0.23%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y57.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y164.29%
OCF growth 3YN/A
OCF growth 5YN/A